EYE · National Vision Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $543.88M | $487.33M | $486.42M | $510.32M | - | $451.51M | $451.73M | $542.52M | - | $532.36M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $256.09M | $252.34M | $247.17M | $255.53M | - | $233.99M | $231.35M | $245.37M | - | $249.71M |
| Total Operating Expenses | $279.50M | $274.52M | $269.60M | $279.00M | - | $270.41M | $257.56M | $269.45M | - | $354.93M |
| D&A | $23.44M | $22.18M | $22.54M | $22.96M | - | $22.69M | $22.69M | $23.64M | - | $24.41M |
| Operating Income | $45.24M | $9.61M | $16.45M | $26.14M | - | ($8.82M) | $591.0K | $24.41M | - | ($74.60M) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $11.21M | $2.12M | $3.51M | $7.38M | - | ($3.63M) | ($1.56M) | $7.92M | - | ($4.52M) |
| Net Income | $31.18M | $3.37M | $8.72M | $14.19M | - | ($8.47M) | ($3.13M) | $11.69M | - | ($73.80M) |
| EPS - Basic | $0.39 | $0.04 | $0.11 | $0.18 | - | ($0.11) | ($0.04) | $0.15 | - | ($0.94) |
| EPS - Diluted | $0.38 | $0.04 | $0.11 | $0.18 | - | ($0.11) | ($0.04) | $0.15 | - | ($0.94) |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $67.90M | $56.03M | $48.47M | $80.02M | $73.95M | $81.15M | $179.51M | $150.05M | $149.90M | $265.81M |
| Accounts Receivable | $43.99M | $46.13M | $45.96M | $53.17M | $49.94M | $46.80M | $61.07M | $74.27M | $86.85M | $76.64M |
| Inventory | $107.71M | $88.01M | $89.65M | $88.57M | $93.92M | $87.59M | $90.96M | $118.56M | $119.91M | $120.58M |
| Accounts Payable | $87.18M | $74.26M | $65.10M | $36.66M | $53.64M | $39.56M | $49.97M | $60.80M | $67.56M | $62.88M |
| Current Assets | $260.62M | $220.19M | $217.70M | $254.12M | $249.83M | $243.72M | $364.40M | $378.91M | $396.67M | $500.06M |
| Total Assets | $2.02B | $1.96B | $1.97B | $2.01B | $2.01B | $2.02B | $2.15B | $2.16B | $2.17B | $2.27B |
| Current Liabilities | $418.49M | $416.96M | $418.25M | $468.21M | $468.27M | $426.12M | $663.16M | $375.01M | $397.70M | $373.53M |
| Long-term Debt | $220.04M | $229.74M | $247.94M | $236.07M | $239.15M | $242.20M | $132.44M | $436.31M | $437.68M | $538.03M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $898.01M | $858.76M | $850.58M | $836.16M | $816.33M | $840.00M | $843.41M | $841.32M | $829.42M | $840.35M |
| Retained Earnings | $286.90M | $252.40M | $249.03M | $240.30M | $226.12M | $254.71M | $263.18M | $266.30M | $254.62M | $270.60M |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $61.70M | - | - | $32.24M | - | - | - | $23.99M | - | - |
| Investing Cash Flow | ($18.27M) | - | - | ($20.23M) | - | - | - | ($18.21M) | - | - |
| Financing Cash Flow | ($14.14M) | - | - | ($5.40M) | - | - | - | ($5.17M) | - | - |
| CapEx | $17.57M | - | - | $20.23M | - | - | - | $20.01M | - | - |
| Free Cash Flow | $44.14M | - | - | $12.01M | - | - | - | $3.97M | - | - |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 8.3% | 2.0% | 3.4% | 5.1% | - | -2.0% | 0.1% | 4.5% | - | -14.0% |
| EBITDA margin | 12.6% | 6.5% | 8.0% | 9.6% | - | 3.1% | 5.2% | 8.9% | - | -9.4% |
| Net margin | 5.7% | 0.7% | 1.8% | 2.8% | - | -1.9% | -0.7% | 2.2% | - | -13.9% |
| Free cash flow margin | 8.1% | - | - | 2.4% | - | - | - | 0.7% | - | - |
| FCF / Net income | 1.42 | - | - | 0.85 | - | - | - | 0.34 | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 47.1% | 51.8% | 50.8% | 50.1% | - | 51.8% | 51.2% | 45.2% | - | 46.9% |
| Effective tax rate | 26.4% | 38.6% | 28.7% | 34.2% | - | - | - | 40.4% | - | - |
| Return on assets | 1.5% | 0.2% | 0.4% | 0.7% | - | -0.4% | -0.1% | 0.5% | - | -3.3% |
| Return on equity | 3.5% | 0.4% | 1.0% | 1.7% | - | -1.0% | -0.4% | 1.4% | - | -8.8% |
| Return on invested capital | 3.0% | 0.5% | 1.1% | 1.6% | - | -0.6% | 0.0% | 1.1% | - | -4.3% |
| Liquidity | ||||||||||
| Current ratio | 0.62 | 0.53 | 0.52 | 0.54 | 0.53 | 0.57 | 0.55 | 1.01 | 1.00 | 1.34 |
| Quick ratio | 0.37 | 0.32 | 0.31 | 0.35 | 0.33 | 0.37 | 0.41 | 0.69 | 0.70 | 1.02 |
| Cash ratio | 0.16 | 0.13 | 0.12 | 0.17 | 0.16 | 0.19 | 0.27 | 0.40 | 0.38 | 0.71 |
| Leverage | ||||||||||
| Debt / Equity | 0.25 | 0.27 | 0.29 | 0.28 | 0.29 | 0.29 | 0.16 | 0.52 | 0.53 | 0.64 |
| Debt / Assets | 0.11 | 0.12 | 0.13 | 0.12 | 0.12 | 0.12 | 0.06 | 0.20 | 0.20 | 0.24 |
| Debt / EBITDA | 3.20 | 7.23 | 6.36 | 4.81 | - | 17.46 | 5.69 | 9.08 | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.25 | 2.28 | 2.31 | 2.40 | 2.46 | 2.40 | 2.54 | 2.56 | 2.62 | 2.70 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.27 | 0.25 | 0.25 | 0.25 | - | 0.22 | 0.21 | 0.25 | - | 0.23 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 30d | 35d | 34d | 38d | - | 38d | 49d | 50d | - | 53d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 62.3x | 713.5x | 210.6x | 71.2x | - | - | - | 147.7x | - | - |
| P / B | 2.1x | 2.7x | 2.2x | 1.2x | - | 1.0x | 1.2x | 2.1x | - | 1.5x |
| P / S | 3.5x | 4.8x | 3.8x | 2.0x | - | 1.9x | 2.3x | 3.2x | - | 2.4x |
| EV / EBITDA | 30.3x | 78.4x | 52.7x | 23.9x | - | 74.1x | 42.2x | 42.3x | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 6.6% | 7.9% | 7.7% | -5.9% | - | -15.2% | -14.0% | -3.5% | - | 6.6% |
| Revenue CAGR (3y) | -1.1% | -0.8% | -1.5% | -1.1% | - | -4.5% | -6.3% | 0.5% | - | 3.1% |
| Revenue CAGR (5y) | 0.4% | 0.1% | 13.3% | 1.7% | - | 0.9% | 1.0% | 3.3% | - | 9.0% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 73.1% | - | 2683.2% | 7.1% | - | 88.2% | -92.3% | -26.7% | - | - |
| Net income growth (YoY) | 119.8% | - | - | 21.4% | - | 88.5% | - | -36.0% | - | - |
| EPS growth (YoY) | 111.1% | - | - | 20.0% | - | 88.3% | - | -31.8% | - | - |
| EPS CAGR (3y) | 20.0% | -35.6% | -2.9% | -19.1% | - | - | - | -32.1% | - | - |
| EPS CAGR (5y) | -4.6% | -37.5% | - | 8.4% | - | - | - | -6.5% | - | - |
| FCF growth (YoY) | 267.4% | - | - | 202.4% | - | - | - | -91.4% | - | - |
| FCF CAGR (5y) | -11.5% | - | - | -30.3% | - | - | - | -41.3% | - | - |
| Book value growth (YoY) | 7.4% | 2.2% | 0.9% | -0.6% | -1.6% | -0.0% | -7.2% | -6.2% | -8.0% | -7.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-03.
Business segments
$1.98B totalOwned And Host Store Brands$1.98B · 100.0%
Product / service
$3.97B totalProduct Sales$1.60B · 40.4%
Eyeglasses And Sunglasses$1.27B · 31.9%
Services And Plans$382.90M · 9.6%
Contact Lenses$324.20M · 8.2%
Exam$254.70M · 6.4%
Product Protection Plans$73.56M · 1.9%
Eyecare Clubs$54.63M · 1.4%
Accessories And Other$11.27M · 0.3%
Peer comparison
Same SIC group: Ophthalmic Goods
Comparing National Vision Holdings against the 5 most active filers in the same SIC group.